Discontinued — last reported Q4 '19
CVS Health AFS and Trading Securities - Unrealized Loss Position (<12 Months) Accumulated Loss decreased by 27.4% to $1.11K in Q3 2025 compared to the prior quarter. Year-over-year, this metric grew by 125.2%, from $493.00 to $1.11K. Over 4 years (FY 2020 to FY 2024), AFS and Trading Securities - Unrealized Loss Position (<12 Months) Accumulated Loss shows an upward trend with a 76.1% CAGR.
afs_debt_securities_unrealized_loss_less_12m_acc| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | 1.7K | 2.2K | 3.7K | 7.7K | 10.4K | 11.4K | 9.5K | 4.8K | 4.8K | 4.5K | 1.2K | 2.6K | 3.5K | 493 | 4.5K | 3K | 1.5K | 1.1K |
| QoQ Change | — | +34.9% | +65.0% | +108.7% | +34.5% | +9.4% | -16.4% | -49.5% | -0.1% | -5.8% | -73.8% | +122.9% | +32.7% | -85.9% | +813.2% | -33.1% | -49.3% | -27.4% |
| YoY Change | — | — | — | — | +524.4% | +406.6% | +156.8% | -37.9% | -53.9% | -60.3% | -87.6% | -45.1% | -27.0% | -89.1% | +280.9% | +14.3% | -56.3% | +125.2% |